Recent research presented at the European Congress on Obesity suggests that combining weight loss medications with behavioral programs leads to a larger reduction in intrusive thoughts about food than behavioral therapy alone. The findings provide evidence that medications known as glucagon-like peptide-1 receptor agonists help quiet the constant mental chatter about eating. A related study published in the journal Obesity outlines the creation of a new tool to measure these persistent thoughts.
Many people trying to manage their weight report experiencing a constant internal dialogue about what, when, and how much to eat. Scientists refer to this phenomenon as food noise. The concept involves persistent and intrusive thoughts about food that disrupt daily life and make healthy choices difficult.
Patients describe this experience as a continuous flow of food-related thoughts even when they are not physically hungry. They might spend large portions of their day planning their next meal or worrying about what they recently ate. These thoughts can easily distract them from their work, family, and daily responsibilities. Historically, it has been difficult to measure this cognitive aspect of weight management because it is an entirely internal experience.
Recently, a class of medications called glucagon-like peptide-1 receptor agonists has gained widespread attention for treating obesity. These drugs mimic a natural hormone in the body that helps regulate appetite and blood sugar. Patients using these medications frequently report a sudden and dramatic drop in their mental chatter about food.
Based on these personal accounts, researchers wanted to test if these medications actually reduce food noise more effectively than traditional behavioral treatments. Behavioral treatments usually involve digital or in-person programs that encourage diet and exercise modifications. To conduct this type of research, scientists first needed a reliable way to measure the mental chatter.
Until recently, no validated survey existed to quantify how often people experience these intrusive thoughts. This gap in measurement tools prompted the initial study to develop and test a standard questionnaire. The scientists aimed to create a tool that could be used easily in both clinical settings and future experiments.
To create the measurement tool, the authors of the paper in the journal *Obesity* first consulted nine experts to review potential questions. They refined the wording to ensure it accurately captured the disruptive nature of food-related thoughts. They also adjusted the language so that the survey read at a fourth-grade reading level, making it highly accessible to the general public.
The team then recruited four hundred adults to take the online survey. Participants reported their demographic information, height, weight, and dieting history. The final analysis included three hundred ninety-six individuals who successfully completed every question on the survey.
Most participants in this survey development group were white and female. The average age was about fifty-one years, and the average body mass index was thirty-one. Body mass index is a standard calculation based on height and weight used to categorize a person’s body size.
The initial survey included seven items, but the researchers removed two redundant questions. The final questionnaire asks participants to rate their agreement with five statements on a scale from zero to four. These statements cover concepts like thinking about food constantly, feeling that these thoughts are uncontrollable, and feeling distracted by food.
The total score ranges from zero to twenty, with higher scores indicating more severe food noise. To test if the survey was consistent, one hundred fifty participants took the questionnaire again seven days later. The scores remained highly consistent over the one-week period, which suggests the tool is a reliable scientific measure.
The remaining two hundred fifty participants answered additional surveys measuring depression, stress, and anxiety. This step helped verify that the new questionnaire measured a unique concept rather than general mental health struggles. A good psychological survey must prove that it is not accidentally measuring a completely different condition. The scientists found that the tool accurately measured food noise as a distinct experience, separating it from general anxiety or mood disorders.
The team also noticed some interesting demographic trends in the survey data. Women tended to have higher scores than men, and people who were actively dieting reported more intrusive thoughts about food. Participants with a higher body mass index also reported higher levels of food noise. In contrast, retired individuals and adults over the age of fifty-five reported lower scores.
With a reliable tool established, the researchers proceeded to test how weight loss medications affect these thoughts in a clinical setting. This observational study included four hundred seventeen adults enrolled in a digital behavioral weight management program. The researchers collected data at the beginning of the study and one month later using the newly validated questionnaire.
The sample included ninety-two participants who started taking a glucagon-like peptide-1 medication alongside their behavioral program. Another three hundred twenty-five participants engaged in the behavioral program without taking the medication. The researchers excluded anyone who was already using weight loss drugs at the start of the program.
Most of the participants in this medication study were white and female. The average age was fifty-nine years, and the average body mass index was thirty-four. The scientists used statistical models to compare how the scores changed over the one-month period between the two groups.
To ensure a fair comparison, the researchers adjusted their statistical models to account for the participants’ starting scores. At the beginning of the study, both groups had similar adjusted scores of around eleven out of twenty. After one month, both groups experienced a drop in food noise.
Participants who only used the behavioral program saw their scores decrease by an adjusted average of one point two. Participants who took the medication alongside the behavioral program saw a much larger drop. The medication group experienced a decrease of just over four points on the questionnaire.
When comparing the two groups, the medication users had a three-point greater reduction in their scores. This difference provides evidence that the medication significantly quiets persistent thoughts about food compared to behavioral changes alone. The authors suggest that this early drop in mental chatter might indicate how well a patient is responding to the treatment.
While these findings are informative, there are a few limitations to consider. The study looking at medication use only tracked participants for one month. Because of this short timeframe, it is not known if the reduction in intrusive thoughts lasts over a longer period.
The researchers note that future studies should examine patients over many months or years. Tracking long-term changes could help scientists understand how reducing mental chatter about food affects overall health and weight loss success. Longer studies would also show if the thoughts return if a patient stops taking the medication.
Another limitation is the demographic makeup of both studies. The participants in both samples were predominantly white and female. Future research should include more diverse groups to see if the findings apply equally to men and people of different racial and ethnic backgrounds.
Additionally, the medication study was observational rather than a randomized controlled trial. This means participants chose whether to take the medication, which can sometimes introduce bias. A randomized controlled trial is a type of study where participants are randomly assigned to different treatments, which provides stronger scientific evidence. The authors suggest that such trials are needed to confirm these early findings.
Finally, the researchers plan to look deeper into the relationship between actual weight loss and the reduction of mental chatter. Analyzing how changes in body weight correspond to changes in thought patterns will be an important next step for the scientific community. Exploring this connection could offer new ways to support patients during their weight management journeys. This future work might reveal whether quieting the mind is a necessary step for achieving long-lasting physical changes.
The study, “Changes in Food Noise in Two Weight Management Programs: Effects of GLP-1 Receptor Agonists,” was authored by Hanim E. Diktas, Stephanie P. Goldstein, Michelle I. Cardel, Gary D. Foster, and Corby K. Martin.
The study, “Development and validation of the Food Noise Questionnaire,” was authored by Hanim E. Diktas, Michelle I. Cardel, Gary D. Foster, Monique M. LeBlanc, Stephanie L. Dickinson, Erin M. Ables, Xiwei Chen, Rebecca Nathan, Danielle Shapiro, and Corby K. Martin.
